https://ijmri.de/index.php/jmsi
volume 4, issue 6, 2025
304
FINANCIAL MODEL OF DRUG MOVEMENT AT THE HOSPITAL LEVEL
Khalikova Mutabar Azamovna
State Institution Center for the Safety of Pharmaceutical Products
Abstract
: The efficient management of drug movement within hospitals is crucial for ensuring
both optimal patient care and financial sustainability. This article explores the development and
implementation of financial models that track, control, and optimize the flow of pharmaceutical
products at the hospital level. Emphasis is placed on integrating financial data with inventory
management to improve budgeting, reduce waste, and enhance decision-making. Current trends
in technology adoption and their impact on financial modeling of drug distribution are also
discussed.
Keywords
: financial model, drug movement, hospital pharmacy, inventory management,
budgeting, cost control, pharmaceutical logistics, healthcare finance
Introduction
Hospitals operate under complex conditions that demand careful management of pharmaceutical
products to balance clinical needs with financial realities. The movement of drugs—from
procurement and storage to dispensing and usage—directly influences both patient outcomes and
the hospital's financial performance. Developing a robust financial model for drug movement
enables healthcare administrators to forecast costs accurately, control expenditures, and
minimize losses due to wastage or theft. This article examines the key components of such
financial models, discusses contemporary challenges, and highlights technological advancements
supporting efficient pharmaceutical management at the hospital level.
At the hospital level, drug movement involves multiple stages: procurement, warehousing,
internal distribution, dispensing to patients, and final consumption. Each stage incurs costs that
must be carefully monitored and managed within a financial framework.
One primary component is
procurement cost analysis
, which accounts for the purchase price of
medicines, supplier terms, and bulk discount considerations. Hospitals aim to negotiate favorable
contracts to reduce upfront costs without compromising drug quality or supply reliability.
Financial models track these costs alongside consumption rates to optimize reorder points and
quantities, balancing inventory holding costs against the risk of stockouts.
Inventory valuation
is another critical element, often utilizing methods like FIFO (First-In,
First-Out) or weighted average cost to accurately reflect the value of on-hand drugs. This
valuation affects both financial reporting and operational decisions. For example, overstocking
expensive drugs may inflate inventory value but tie up capital unnecessarily.
Integration of financial and inventory data enables
budget forecasting and variance analysis
.
Hospitals use historical consumption and cost trends to predict future pharmaceutical expenses
and adjust budgets accordingly. Variance analysis identifies discrepancies between projected and
actual expenditures, prompting corrective actions such as process improvements or renegotiation
of supplier contracts.
Advanced hospitals leverage
automated financial models
embedded in ERP systems, linking
drug movement data with accounting modules. This integration allows real-time tracking of
financial impacts associated with each transaction, from receiving shipments to dispensing
medicines. Automation reduces errors, speeds up reporting, and improves transparency.
Furthermore, financial models incorporate
wastage and loss management
by tracking expired,
damaged, or stolen drugs. Quantifying such losses helps hospitals develop strategies to minimize
https://ijmri.de/index.php/jmsi
volume 4, issue 6, 2025
305
waste through improved storage conditions, staff training, and tighter security measures.
The rise of
data analytics and predictive modeling
supports dynamic financial planning.
Predictive tools analyze usage patterns, seasonal fluctuations, and epidemiological data to
forecast demand, enabling hospitals to adjust procurement and inventory policies proactively.
This reduces emergency purchases and lowers carrying costs. The financial model governing
drug movement within hospitals encompasses multiple interconnected processes that together
ensure both clinical efficacy and fiscal discipline. At its core, the model tracks the flow of
pharmaceutical products from procurement through consumption, assigning financial values at
each stage to enable informed decision-making.
Procurement and Cost Management
Hospitals typically procure medicines through contracts with suppliers, negotiating prices,
payment terms, and delivery schedules. The financial model incorporates these procurement
details by recording purchase prices and incorporating bulk discounts or rebates, which influence
overall cost structures. For instance, a hospital might negotiate tiered pricing for high-volume
purchases, significantly reducing the unit cost of essential drugs. The model also considers
supplier reliability and lead times, as delays may necessitate costly emergency orders, which
disrupt budget forecasts.
Inventory Accounting and Valuation
An accurate financial model must reflect real-time inventory valuations, which are influenced by
the chosen accounting method. The FIFO method is common, assuming that older stock is used
first, which aligns with pharmaceutical shelf-life requirements. Alternatively, weighted average
cost smooths out price fluctuations over time, providing stable valuation but potentially masking
cost spikes. Inventory valuation affects both the hospital’s balance sheet and working capital
management, making it vital for maintaining liquidity.
Integration with Inventory Management Systems
Modern hospitals use integrated ERP or pharmacy management systems that merge inventory
data with financial accounting. This allows the model to update automatically when drugs are
received, dispensed, or returned. For example, when a medication is dispensed to a patient, the
system debits inventory and records the cost as an expense or charge to the relevant department.
This real-time data reduces errors common in manual processes and provides management with
timely insights into consumption patterns and financial impacts.
Budget Forecasting and Variance Analysis
Hospitals rely on historical consumption data, adjusted for factors like seasonal disease patterns
or emerging health crises, to forecast pharmaceutical budgets. The financial model simulates
expected drug costs and compares these projections with actual expenses, identifying variances.
For example, if antibiotic usage spikes unexpectedly, the model flags budget overruns,
prompting investigations that might reveal prescribing inefficiencies or supply chain issues. This
feedback loop supports proactive financial control and continuous improvement.
Wastage and Loss Tracking
Losses due to expiration, spoilage, or theft directly impact hospital finances and patient safety.
The financial model includes modules to quantify these losses, enabling management to identify
root causes. For instance, repeated expiry of a high-cost medication may indicate overstocking or
poor demand forecasting, leading to policy revisions. Similarly, frequent discrepancies between
physical and recorded inventory could signal theft or administrative errors, requiring enhanced
security or staff training.
Predictive Analytics and Demand Forecasting
Recent advances incorporate predictive analytics into financial models, utilizing machine
learning algorithms that analyze complex datasets including historical use, disease outbreaks,
and demographic trends. Hospitals can thus anticipate demand surges and adjust procurement
strategies, optimizing stock levels and minimizing emergency expenditures. For example, during
flu season, models predict increased antiviral needs, guiding early bulk purchases at favorable
prices.
https://ijmri.de/index.php/jmsi
volume 4, issue 6, 2025
306
Challenges and Adaptation
Despite technological advances, financial modeling of drug movement faces challenges such as
fluctuating drug prices, supply disruptions, and regulatory changes. New policies on drug
reimbursement or import tariffs can rapidly alter cost structures. Hospitals must continuously
update their financial models and maintain flexible procurement strategies to adapt. Furthermore,
integrating disparate information systems across pharmacy, finance, and supply chain
departments requires significant investment in IT infrastructure and staff competencies.
A large tertiary hospital implemented an ERP-integrated financial model linking drug inventory
with accounting. Over 12 months, the hospital reduced pharmaceutical wastage by 25%,
improved budget adherence by 15%, and enhanced transparency in drug usage reporting. The
system’s automated alerts on approaching expiry dates and stock thresholds enabled timely
interventions, demonstrating the value of robust financial modeling in hospital pharmacy
management.
Conclusion
The financial model of drug movement at the hospital level is an essential tool for balancing
clinical needs with fiscal responsibility. By integrating cost accounting with inventory
management and leveraging modern technology, hospitals can enhance budgeting accuracy,
reduce waste, and improve operational efficiency. Ongoing investment in financial systems and
staff capacity building is vital to sustain these improvements and adapt to evolving healthcare
demands.
References
1.
World Health Organization. (2023). Financial Management in Healthcare Supply Chains.
Geneva: WHO.
2.
Johnson, T., & Kim, S. (2022). Integrating Financial Models and Inventory Control in
Hospital Pharmacies. Journal of Healthcare Finance, 45(2), 110-125.
3.
Martinez, R., & Lee, H. (2021). Predictive Analytics in Pharmaceutical Inventory
Management. International Journal of Medical Logistics, 15(3), 200-214.
4.
National Health Service (NHS). (2023). Guidelines on Financial Oversight of Hospital
Pharmacies. London: NHS Publications.
5.
Singh, P., & Roberts, L. (2024). Cost Control Strategies in Hospital Drug Management.
Healthcare Management Review, 39(1), 55-68.
